Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Late-onset multiple sclerosis is associated with relapse-independent disability accrual: a propensity score-weighted recurrent-event study.

Journal of neurology·2026
Same author

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Journal of neurology·2026
Same author

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

CNS drugs·2026
Same journal

MMFVS-Net: A triple-symmetric cross-attention network for multimodal optical image fusion and high-accuracy virtual staining of breast cancer tissues.

Computer methods and programs in biomedicine·2026
Same journal

A novel Milstein-stochastic epidemiologically-informed neural network for approaching epidemic dynamics: Application to Mpox disease.

Computer methods and programs in biomedicine·2026
Same journal

Accounting for approximation errors using surrogate-based parameter estimation of cardiac mechanics digital twins.

Computer methods and programs in biomedicine·2026
Same journal

Facial iPPG heatmap patterns based on period-aware autoencoder show association with carotid atherosclerosis towards non-contact hemodynamic assessment.

Computer methods and programs in biomedicine·2026
Same journal

Explainable machine learning models predict liver fibrosis risk and outcome in the general population: Development and multi-cohort external validation.

Computer methods and programs in biomedicine·2026
Same journal

Evaluation of surrogate endpoints for survival outcomes using the surrogate package in R.

Computer methods and programs in biomedicine·2026
See all related articles

Related Experiment Video

Updated: May 27, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.6K

Explainable time-to-progression predictions in multiple sclerosis.

Robbe D'hondt1, Klest Dedja1, Sofie Aerts2

  • 1KU Leuven, Dept. Public Health and Primary Care, Kortrijk, Belgium; itec, imec research group at KU Leuven, Kortrijk, Belgium.

Computer Methods and Programs in Biomedicine
|February 18, 2025
PubMed
Summary
This summary is machine-generated.

This study models time to multiple sclerosis disability progression using explainable machine learning, offering more personalized patient prognosis than traditional binary models. It achieves state-of-the-art predictions and provides clinically valid insights.

Keywords:
Disability progressionExplainable artificial intelligenceLongitudinal dataMultiple sclerosisSurvival analysis

More Related Videos

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.5K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.8K

Related Experiment Videos

Last Updated: May 27, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.6K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.5K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.8K

Area of Science:

  • Machine learning applications in neurology
  • Survival analysis in clinical research
  • Explainable artificial intelligence in healthcare

Background:

  • Current multiple sclerosis (MS) prognostic models use binary predictions, failing to account for individual disease severity.
  • There is a need for more nuanced prognostic tools in MS research.

Purpose of the Study:

  • To model the time to disability progression in MS patients.
  • To enhance model interpretability using explainable machine learning techniques.

Main Methods:

  • Utilized a subset of 29,201 patients from the MSBase registry.
  • Employed random survival forests for time-to-event prediction of disability progression (Expanded Disability Status Scale).
  • Applied SHAP and Bellatrex for model explainability, providing global and local insights.

Main Results:

  • Random survival forest achieved state-of-the-art performance, comparable to prior random forest models.
  • The model accurately predicted progression over a 10-year horizon (AUROC >60%).
  • Explainability techniques revealed clinically relevant insights, such as the impact of recent MS therapies on progression rates.

Conclusions:

  • Transitioning from binary classification to time-to-event modeling in MS prognosis does not compromise performance.
  • Explainable AI is crucial for understanding and validating prognostic models in MS care.
  • This approach allows for more comprehensive and personalized patient prognosis.